These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 36675073)
61. A phase I trial of carboplatin administered by convection-enhanced delivery to patients with recurrent/progressive glioblastoma multiforme. White E; Bienemann A; Taylor H; Hopkins K; Cameron A; Gill S Contemp Clin Trials; 2012 Mar; 33(2):320-31. PubMed ID: 22101221 [TBL] [Abstract][Full Text] [Related]
67. Comparative analysis of antioxidative systems in malignant and benign brain tumours. Bogosavljević V; Bajčetić M; Spasojević I Redox Rep; 2015 Mar; 20(2):69-74. PubMed ID: 25247681 [TBL] [Abstract][Full Text] [Related]
68. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Wolburg H; Wolburg-Buchholz K; Kraus J; Rascher-Eggstein G; Liebner S; Hamm S; Duffner F; Grote EH; Risau W; Engelhardt B Acta Neuropathol; 2003 Jun; 105(6):586-92. PubMed ID: 12734665 [TBL] [Abstract][Full Text] [Related]
69. Tropomyosin Tpm 2.1 loss induces glioblastoma spreading in soft brain-like environments. Mitchell CB; Black B; Sun F; Chrzanowski W; Cooper-White J; Maisonneuve B; Stringer B; Day B; Biro M; O'Neill GM J Neurooncol; 2019 Jan; 141(2):303-313. PubMed ID: 30535593 [TBL] [Abstract][Full Text] [Related]
70. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature. Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514 [TBL] [Abstract][Full Text] [Related]
71. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126 [TBL] [Abstract][Full Text] [Related]
72. Psychopharmacology of fluoride: a review. Spittle B Int Clin Psychopharmacol; 1994; 9(2):79-82. PubMed ID: 8056997 [TBL] [Abstract][Full Text] [Related]
73. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis. Chen X; Pan Y; Yan M; Bao G; Sun X Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990 [TBL] [Abstract][Full Text] [Related]
74. Erlotinib: early clinical development in brain cancer. Addeo R; Zappavigna S; Parlato C; Caraglia M Expert Opin Investig Drugs; 2014 Jul; 23(7):1027-37. PubMed ID: 24836441 [TBL] [Abstract][Full Text] [Related]
75. Pharmacokinetic considerations in the treatment of CNS tumours. Motl S; Zhuang Y; Waters CM; Stewart CF Clin Pharmacokinet; 2006; 45(9):871-903. PubMed ID: 16928151 [TBL] [Abstract][Full Text] [Related]
76. [Glioblastoma, an example of translational research?]. Kroonen J; Nguyen-Khac MT; Deprez M; Rogister B; Robe P Rev Med Liege; 2008; 63(5-6):251-6. PubMed ID: 18669189 [TBL] [Abstract][Full Text] [Related]
77. Safety and Efficacy Assessments to Take Antioxidants in Glioblastoma Therapy: From In Vitro Experiences to Animal and Clinical Studies. Turkez H; Tozlu OO; Arslan ME; Mardinoglu A Neurochem Int; 2021 Nov; 150():105168. PubMed ID: 34450218 [TBL] [Abstract][Full Text] [Related]
78. Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastoma. Kulason KO; Schneider JR; Chakraborty S; Filippi CG; Pramanik B; Wong T; Fralin S; Tan K; Ray A; Alter RA; Ortiz R; Demopoulos A; Langer DJ; Boockvar JA J Exp Ther Oncol; 2018 May; 12(3):223-229. PubMed ID: 29790314 [TBL] [Abstract][Full Text] [Related]
79. Contribution of the Wnt Pathway to Defining Biology of Glioblastoma. Tompa M; Kalovits F; Nagy A; Kalman B Neuromolecular Med; 2018 Dec; 20(4):437-451. PubMed ID: 30259273 [TBL] [Abstract][Full Text] [Related]